Compounds > dabigatran
Page last updated: 2024-09-05

dabigatran and Brachial Paresis

dabigatran has been researched along with Brachial Paresis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaneko, N; Ohtani, T; Sintoku, R; Yajima, T1
Eder, V; Haring, HP; Müller, P; Nesser, HJ; Nußbaumer, K; Sonnberger, M; Topakian, R; Trenkler, J; Windpessl, M1
Dogné, JM; Douxfis, J; Laloux, P; Larock, AS; Mullier, F; Spinewine, A1
Berrouschot, J; Eschenfelder, CC; Hogh, T; Stoll, A1

Other Studies

4 other study(ies) available for dabigatran and Brachial Paresis

ArticleYear
Successful thrombolytic therapy with recombinant tissue plasminogen activator in ischemic stroke after idarucizumab administration for reversal of dabigatran: a case report.
    Journal of medical case reports, 2019, Dec-26, Volume: 13, Issue:1

    Topics: Aged; Antibodies, Monoclonal, Humanized; Dabigatran; Dysarthria; Female; Humans; Paresis; Stroke; Tissue Plasminogen Activator; Treatment Outcome

2019
Endovascular thrombectomy for acute ischemic stroke patients anticoagulated with dabigatran.
    Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:10

    Topics: Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Cerebral Angiography; Dabigatran; Endovascular Procedures; Female; Heart Failure; Humans; Paresis; Stroke; Thrombectomy; Tomography, X-Ray Computed; Treatment Outcome

2013
[The mirages of the new oral anticoagulants].
    Journal de pharmacie de Belgique, 2014, Issue:1

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Drug Interactions; Humans; Male; Paresis; Pharmacy Service, Hospital; Pyridines; Stroke

2014
Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab.
    Stroke, 2016, Volume: 47, Issue:7

    Topics: Aged; Antibodies, Monoclonal, Humanized; Antidotes; Atrial Fibrillation; Brain Ischemia; Dabigatran; Diabetes Mellitus, Type 2; Humans; Hypertension; Infarction, Middle Cerebral Artery; Male; Paresis; Recombinant Proteins; Recovery of Function; Severity of Illness Index; Thrombolytic Therapy; Thrombophilia; Tissue Plasminogen Activator

2016